Skip To Main Content
Institut Bourdonnais on Muck Rack

Institut Bourdonnais

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Institut Bourdonnais’s profile

Articles by Institut Bourdonnais

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis

|
By Institut Bourdonnais, Michael Gnant, Suhail Muzaffar, Martine Marie
| Frontiers
1 Introduction In France, breast cancer (BC) is the most prevalent cancer in women, with 58,083 new cases in 2020 (1). The most common subtype of BC, accounting for 70% of all female cases, is hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) BC (2, 3). Surgery followed by adjuvant systemic therapy is the mainstay of treatment for early BC.
Open in Who Shared Issue with article?

Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis

|
By Lower Normandy, Institut Bourdonnais
| Frontiers
Genomic signature to guide adjuvant chemotherapy treatment decisions for early breast cancer patients in France: a cost-effectiveness analysis 1University of Franche-Comté, France 2INSERM U1098 Interactions Hôte-Greffon-Tumeur & Ingénierie Cellulaire et Génique, France 3École des Hautes Etudes en Santé Publique, France 4Institut Bourdonnais, France 5Institut de Cancérologie de l'Ouest (ICO), France 6Creativ-Ceutical, France 7Centre François Baclesse, France The final, formatted version of the...
Open in Who Shared Issue with article?
Show More